Recently, biallelic loss-of-function (LoF) variants of CARMIL2 have been linked to very early onset inflammatory bowel disease (IBD) or IBD-like inflammatory gastrointestinal disorder, with or without clinical manifestations of immunodeficiency11,13,15–18. Here, CARMIL2 is linked to inflammatory bowel disease.